Lorcaserin: all 47 studies that test it
Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.
- A Study of Lorcaserin as Adjunctive Treatment in Participants With Dravet SyndromeTerminatedNCT04572243Phase 3Results posted
- Laboratory Screening of Lorcaserin for Alcohol Use DisorderTerminatedNCT04396847Phase 2Results posted
- Mechanisms of Lorcaserin for Smoking CessationTerminatedNCT04396834Phase 2Results posted
- Lorcaserin for Cannabis Use DisorderTerminatedNCT03637842Early Phase 1Results posted
- Predictors of Lorcaserin-Induced Weight LossTerminatedNCT03353220Phase 4Results posted
- Study to Evaluate the Efficacy and Safety of Belviq XR® in Conjunction With Lifestyle Modification for Weight Loss in Obese Adolescents, Age 12 to 17 YearsTerminatedNCT03338296Phase 4Results posted
- Effect of Lorcaserin on Cannabis Withdrawal and Self-administrationCompletedNCT03253926Phase 1/2Results posted
- Treatment With Lorcaserin for Cocaine Use: The TLC StudyTerminatedNCT03192995Phase 2Results posted
- Lorcaserin in Combination With XR-Naltrexone for Relapse Prevention in Opioid Use DisorderCompletedNCT03169816Phase 2/3Results posted
- Drug Interaction and Subjective Effects of Compounds for Opioid Use DisorderCompletedNCT03143855Phase 1Results posted
- Lorcaserin in the Treatment of Cocaine Use DisorderCompletedNCT03007394Phase 2Results posted
- Combination Nicotine Patch / Lorcaserin for Smoking CessationCompletedNCT02906644Phase 2Results posted
- MEtformin and Lorcaserin for WeighT Loss in SchizophreniaTerminatedNCT02796144Phase 4Results posted
- Evaluating Muscle Weakness Improvement With Lorcaserin in ICUTerminatedNCT02523690Phase 1/2Results posted
- Addressing Post Cessation Weight GainTerminatedNCT02412631Phase 2/3Results posted
- Lorcaserin for Preventing Weight Gain Among SmokersCompletedNCT02393547Phase 1/2Results posted
- Lifestyle Modification and Lorcaserin for Weight Loss MaintenanceCompletedNCT02388568Not applicableResults posted
- Low Level Laser Treatment (LLLT) and Lorcaserin for Weight ManagementCompletedNCT02129608Phase 3Results posted
- A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking CessationCompletedNCT02044874Phase 2Results posted
- A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk FactorsCompletedNCT02019264Phase 4Results posted
- A Multicenter, Double-blind, Randomized, Parallel-group, Pilot Study of 12-week Duration to Assess the Short-term Safety and Tolerability of Lorcaserin Plus Two Doses of Immediate-Release Phentermine-HCl Compared With Lorcaserin Alone in Overweight and Obese AdultsCompletedNCT01987427Phase 4Results posted
- BLOSSOM: Behavioral Modification and Lorcaserin Second Study for Obesity ManagementCompletedNCT00603902Phase 3Results posted
- BLOOM-DM: Behavioral Modification and Lorcaserin for Overweight and Obesity Management in Diabetes MellitusCompletedNCT00603291Phase 3Results posted
- BLOOM: Behavioral Modification and Lorcaserin for Overweight and Obesity ManagementCompletedNCT00395135Phase 3Results posted
- Lorcaserin in Treating Chemotherapy-Induced Peripheral Neuropathy in Patients With Stage I-IV Gastrointestinal or Breast CancerWithdrawnNCT04205071Phase 1
- Comparing Lorcaserin Versus Duloxetine for the Treatment of Chemotherapy-Induced Peripheral NeuropathyStatus unknownNCT03812523Phase 2
- Lorcaserin and Behavioral Modification for Overweight and Obesity Management in Chinese Obese PatientsTerminatedNCT03720574Phase 3
- A Study to Demonstrate Bioequivalence Between Lorcaserin Extended Release (XR) Tablets Manufactured in Kawashima and Lorcaserin XR Tablets Manufactured in Zofingen in Healthy ParticipantsCompletedNCT03627936Phase 1
- Rebalancing the Serotonergic System in Cocaine DependenceWithdrawnNCT03266939Phase 1
- Phase I Functional Magnetic Resonance Imaging (fMRI) Pharmacodynamic Studies of Compounds for Opioid Use Disorder and Cocaine Use DisorderTerminatedNCT03143543Phase 1
- Gene-by-Stress Interactions in Intervention Studies SignificanceTerminatedNCT03011645Phase 1
- Use of a Mobile Health Sensor in an Open Label Trial of Lorcaserin for the Treatment of Cannabis Use DisorderCompletedNCT02932215Phase 1
- Lorcaserin Intra Venous Cocaine EffectsStatus unknownNCT02680288Phase 1/2
- Lorcaserin in Obesity: Identification of CNS Targets Using fMRIActive, not recruitingNCT02400359Phase 4
- A Single Dose Pharmacokinetic Study of Lorcaserin Hydrochloride in Obese Pediatric Subjects 6 to 11 Years of AgeCompletedNCT02398669Phase 1
- Study to Assess Potential Interactions Between Intravenous Cocaine and Oral LorcaserinCompletedNCT02393599Phase 1
- A Study of APD356 (Lorcaserin) in Healthy Japanese Adult SubjectsCompletedNCT02192515Phase 1
- Single Dose Study to Determine the Safety, Tolerability, and Pharmacokinetic Properties of Lorcaserin Hydrochloride (BELVIQ) in Obese Adolescents From 12 to 17 Years of AgeCompletedNCT02022956Phase 1
- Lorcaserin for Weight Loss Management in Patients on Antipsychotics: A Pilot StudyStatus unknownNCT01962402Phase 4
- Pharmacokinetic Study of Belviq in Adult Korean VolunteersCompletedNCT01880502Phase 1
- To Assess the Effect of Lorcaserin Hydrochloride on Energy Metabolism and Food IntakeCompletedNCT00829140Phase 1
- Pharmacokinetic Properties of Lorcaserin in Subjects With Hepatic ImpairmentCompletedNCT00828932Phase 1
- Pharmacokinetic Properties of Lorcaserin in the Fed and Fasted StateCompletedNCT00828724Phase 1
- Pharmacokinetic Properties of Lorcaserin in Obese or Overweight Elderly SubjectsCompletedNCT00828581Phase 1
- Pharmacokinetic Properties of Lorcaserin in Subjects With Renal ImpairmentCompletedNCT00828438Phase 1
- Safety and Efficacy of APD356 in the Treatment of ObesityCompletedNCT00116740Phase 2
- Safety and Efficacy of APD356 in the Treatment of ObesityCompletedNCT00104507Phase 2